Peptides DB
Research-centric peptide and protocol reference hub
Study 49 of 50VIP (Vasoactive Intestinal Polypeptide) literaturebiorxiv-preprint · Observational2026

Single-nucleus RNA-seq atlas of 5xFAD mouse brain maps cell-type-specific transcriptional disruption and preferential rolipram rescue in VIP interneurons

VIP interneurons show significant transcriptional disruption in Alzheimer's disease, and rolipram preferentially rescues some of these changes, particularly affecting the Pde7b gene.

Read at biorxiv-preprintAdd to compare

Where it sits

this study against the rest of the vip (vasoactive intestinal polypeptide) corpus
10
Preclinical
32
Observational · this one
1
Open-label
2
Randomised
5
Reviews

Summary and findings

This study examined transcriptional changes in VIP interneurons in a 5xFAD mouse model of Alzheimer's disease after treatment with rolipram at a dose of 0.03 mg/kg/day for 30 days. The researchers identified 289 candidate genes with lower expression in 5xFAD VIP interneurons and reported preferential rescue effects from rolipram. Notably, rolipram restored Pde7b expression in these interneurons.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
289 candidate genes were lower in 5xFAD VIP interneurons, padj = 1.5x10^-14.2026

Abstract

The authors’ words, as biorxiv-preprint supplied them

<h4>Background: </h4> Alzheimer's disease is characterized by progressive synaptic dysfunction and inhibitory circuit disruption across multiple brain cell types. Rolipram, a selective phosphodiesterase 4 (PDE4) inhibitor that elevates intracellular cyclic AMP (cAMP), activates proteasome, and produces robust procognitive effects in AD mouse models. Still, the cell-type-specific transcriptional mechanisms underlying these effects remain uncharacterized. <h4>Methods:</h4> We profiled 29,664 nuclei from 5xFAD and wild-type (WT) mouse right hemisphere across four conditions: WT Vehicle, WT Rolipram, 5xFAD Vehicle, and 5xFAD Rolipram (0.03 mg/kg/day, 30-day subcutaneous osmotic pump) using the Parse Biosciences Evercode WT v3 combinatorial barcoding platform. Nuclei were clustered into 16 annotated cell type populations using Seurat v5. Disease and rescue effects were quantified as log fold changes (LFCs) across all clusters, with Gene Ontology enrichment assessed using clusterProfiler and transcription factor activity inferred using decoupleR. <h4>Results:</h4> Disease-associated transcriptional disruption was highly cell-type-specific in its magnitude. Among inhibitory subtypes, VIP/Reln disinhibitory interneurons (n = 149 nuclei) showed the most coherent transcriptional disruption: 289 candidate genes were lower in 5xFAD, with Gene Ontology enrichment concentrated in synapse organization programs, including regulation of synapse structure or activity (padj = 1.5x10^-14, 44 genes), regulation of synapse organization (padj = 1.9x10^-14, 43 genes), and postsynapse organization (padj = 1.1x10^-13, 38 genes). This pathway-level specificity was not reproduced in PVALB or SST interneurons. Astrocytes showed loss of cell-adhesion programs (cell-substrate adhesion padj = 2.4x10^-4, 10 genes). Rolipram rescue was preferential: VIP interneurons yielded 72 true rescue genes and astrocytes yielded 42, with the remaining 14 clusters showing substantially fewer. The cAMP-specific phosphodiesterase Pde7b was disease-context-specifically lower in 5xFAD VIP interneurons (LFC -0.53) and restored by rolipram (LFC +0.54), with WT expression unchanged. decoupleR CREB1 activity inference identified reduced CREB1 activity in 5xFAD VIP interneurons with partial restoration in 5xFAD Rolipram, supporting a stepwise transcriptional cascade in which amyloid pathology reduces cAMP, which suppresses PKA and CREB1 activity. This in turn reduces Pde7b transcription, and rolipram reverses this cascade by blocking cAMP hydrolysis upstream. <h4>Conclusion:</h4> This single-nucleus atlas provides the first cell-type-resolved characterization of rolipram's transcriptional effects in the 5xFAD brain. VIP disinhibitory interneurons emerge as the most transcriptionally vulnerable inhibitory subtype and the preferential site of rolipram-associated rescue, with the Pde7b/CREB1 signaling axis nominating a tractable, disease-context-specific pharmacological substrate.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the VIP (Vasoactive Intestinal Polypeptide) corpus

AExploring the therapeutic role of Chinses herbal medicine in the recurrence rate of uterine fibroids after conservative surgery: a systematic review and meta-analysis.Journal of ethnopharmacology · 2026 · n=1627 · OR = 0.22; 95% CI = 0.14-0.34; I2 = 0%; p < 0.00001 for CHM vs blank controls, n = 588reviewBPrefrontal cortex transcriptomes distinguish Alzheimer’s disease from asymptomatic amyloid pathology, neuropeptide loss, immune-complement activation and glial remodellingbiorxiv-preprint · 2026 · n=15 · 341 differentially expressed genes (DEGs) in AD versus Normal, n=8, adjusted P < 0.05.HumanBSex differences in cell type-specific transcriptional programs and GPCR signaling in the human subgenual anterior cingulate cortexbiorxiv-preprint · 2026 · n=19 · Not reported in abstract.HumanDHeterogeneity of microbiome responses to menopausal hormone therapy among perimenopausal women.Nature medicine · 2026—CLongitudinal Imaging in a Mouse Model of Focal Cortical Dysplasia Reveals Lesion Expansion and Loss of Pre-Discharge Neuronal Recruitmentbiorxiv-preprint · 2026 · Not reported in abstract.AnimalCCortex-wide imaging in naturally behaving mice with 1-gram wireless mesoscopes.Nature · 2026Animal